Like smartphones upended everyday tasks from communication to shopping, artificial intelligence promises to change how the pharmaceutical industry discovers drugs, carries out R&D and even ...
(RTTNews.com) - CytoReason, an Israel-based company that uses machine learning for drug discovery and development, said Monday that it has entered into a collaboration agreement with Pfizer Inc. ( PFE ...
Matthew Herper covers medical innovation — both its promise and its perils. SAN FRANCISCO — At the end of a roundtable lunch with a group of reporters, Pfizer CEO Albert Bourla became impassioned. He ...
“Pfizer is a remarkable marketing machine. They have an incredible ability to make the most of molecules and get them adopted,” said Timothy Calkins, a professor of marketing at Northwestern ...
PostEra's machine learning technology is intended to accelerate the drug discovery process by designing novel molecular structures with optimised potency and drug-like properties. PostEra's approaches ...
Vaccines to block COVID-19 that are in development by Moderna, Pfizer, AstraZeneca and others, and that are currently in Phase III clinical trials, may not do as well covering people of Black or Asian ...
I reaffirm my Buy rating on Pfizer due to expected promising updates on danuglipron and strong capital efficiency metrics, despite the recent stock pullback. Pfizer's management is expected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback